Dashboard
Weak Long Term Fundamental Strength with a -54.63% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.21
- The company has been able to generate a Return on Equity (avg) of 3.60% signifying low profitability per unit of shareholders funds
Flat results in Sep 26
Stock DNA
Commodity Chemicals
INR 12 Cr (Micro Cap)
NA (Loss Making)
37
0.00%
0.52
-1.88%
0.93
Total Returns (Price + Dividend) 
Link Pharma Chem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Link Pharma Chem Ltd Valuation Shifts Amidst Market Downturn
Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a sharp decline in its share price and deteriorating financial metrics, raising questions about its price attractiveness relative to peers and historical benchmarks.
Read More
Link Pharma Chem Ltd Valuation Shifts to Fair Amidst Steep Price Decline
Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a challenging market environment and deteriorating financial metrics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read More
Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns
Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite persistent headwinds reflected in its financial performance and market returns, the stock’s price-to-book value and other valuation metrics suggest a potential reappraisal of its price attractiveness relative to peers and historical benchmarks.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2026 | Source : BSENewspaper publication of Unaudited Financial Results of the Company for Quarter and Half year ended September 30 2026 in Business standard (English Edition) and Loksatta (Gujarati Edition).
Unaudited Financial Results Of The Board Meeting Held On 3Rd November 2026
03-Nov-2026 | Source : BSEUnaudited Financial results of the Board meeting held on 3rd November 2026
Board Meeting Outcome for Board Meeting Outcome Of Board Meeting Held On 3Rd November 2026
03-Nov-2026 | Source : BSEBoard meeting outcome of Board Meeting held on 3rd November 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.02%)
Held by 0 FIIs
Rishikesh Satishbhai Thakur (21.95%)
Gurudev Marketing Pvt. Ltd. (5.76%)
36.43%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is -39.22% vs 33.08% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -168.75% vs 178.05% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 3.45% vs -2.08% in Sep 2024
Growth in half year ended Sep 2025 is 4,300.00% vs 99.46% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 9.80% vs -13.21% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 172.06% vs 58.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 7.86% vs -14.95% in Mar 2025
YoY Growth in year ended Mar 2026 is 107.77% vs 24.26% in Mar 2025